# SIL1

## Overview
SIL1 is a gene that encodes the SIL1 nucleotide exchange factor, a co-chaperone protein primarily located in the endoplasmic reticulum of eukaryotic cells. This protein plays a critical role in protein homeostasis by functioning as a nucleotide exchange factor (NEF) for the Hsp70 chaperone BiP, also known as GRP78. SIL1 facilitates the release of ADP from BiP, allowing ATP to bind, which is essential for the protein-folding process within the endoplasmic reticulum. The SIL1 protein is characterized by its armadillo (ARM)-like repeats, which enable its interaction with the BiP ATPase domain, promoting conformational changes necessary for nucleotide exchange. Mutations in the SIL1 gene are linked to Marinesco-Sjögren syndrome, a rare autosomal recessive disorder characterized by cerebellar ataxia, congenital cataracts, and progressive myopathy, highlighting the gene's clinical significance (Anttonen2008Novel; Ichhaporia2021Role).

## Structure
The SIL1 protein is a nucleotide exchange factor for the chaperone protein BiP, primarily located in the endoplasmic reticulum. Its molecular structure is characterized by an elongated, 'kidney bean'-like shape composed of 16 α-helices, forming armadillo (ARM)-like repeats, which are similar to those found in β-catenin (Ichhaporia2021Role; Yan2011Structural). These ARM repeats consist of three α-helices that pack into a superhelix, facilitating the interaction with the BiP ATPase domain (Ichhaporia2021Role).

The core domain of SIL1 is composed of Armadillo repeats flanked by capping helix pairs, which are crucial for its function as a nucleotide exchange factor (Bracher2014GrpE). The protein binds to the lobe IIb region of the BiP ATPase domain, causing conformational changes that promote nucleotide release (Yan2011Structural). This interaction involves extensive charge-charge interactions and numerous hydrogen bonds, with key residues such as His 163 and Glu 390 playing essential roles (Yan2011Structural).

SIL1 functions as a monomer, lacking a quaternary structure, and is involved in ER-associated degradation and the unfolded protein response (Yan2011Structural). Mutations in SIL1 are linked to Marinesco-Sjögren syndrome, affecting its interaction with BiP and leading to neurodegenerative conditions (Inaguma2014).

## Function
The SIL1 gene encodes a co-chaperone protein that functions as a nucleotide exchange factor (NEF) for the Hsp70 chaperone BiP in the endoplasmic reticulum (ER) of eukaryotic cells. SIL1 facilitates the release of ADP from BiP by interacting with its ATPase domain, which is crucial for the protein-folding process within the ER. This interaction involves conformational changes in the BiP ATPase domain, opening the nucleotide-binding pocket and disrupting hydrogen bonds with bound ADP, promoting ADP release and allowing ATP to bind (Behnke2015BiP; Yan2011Structural).

SIL1 is essential for maintaining protein homeostasis by ensuring the proper folding and maturation of nascent proteins, preventing the accumulation of misfolded proteins, and facilitating their degradation through ER-associated degradation (ERAD) (Anttonen2008Novel; Ichhaporia2021Role). It is ubiquitously expressed in human tissues, with particularly high expression in secretory tissues and the brain, where it plays a critical role in neuronal migration and axonal growth during brain development (Inaguma2014; Ichhaporia2021Role). SIL1's function is crucial for normal cellular function and survival, and its deficiency can lead to diseases such as Marinesco-Sjögren syndrome (Gatz2019Identification).

## Clinical Significance
Mutations in the SIL1 gene are primarily associated with Marinesco-Sjögren syndrome (MSS), a rare autosomal recessive disorder. MSS is characterized by cerebellar ataxia, congenital cataracts, progressive myopathy, and mental retardation (Anttonen2008Novel; Ichhaporia2021Role). The SIL1 gene encodes a co-chaperone that functions as a nucleotide exchange factor for the ER chaperone BiP, crucial for protein folding. Mutations in SIL1 lead to protein misfolding and aggregation, triggering the unfolded protein response (UPR) and resulting in cellular stress and degeneration, particularly affecting Purkinje neurons and skeletal muscle fibers (Ruggieri2022Genotypephenotype; Buchkremer2016Sil1Mutant).

The genetic heterogeneity of MSS is evident, as approximately 40% of patients with classical MSS symptoms do not have identifiable mutations in SIL1, suggesting the involvement of other genes in the same pathway (Inaguma2014; Ichhaporia2021Role). Despite the variability in clinical presentation, SIL1 mutations consistently lead to the hallmark features of MSS, although the severity and additional symptoms can vary depending on the specific mutation (Anttonen2008Novel; Bayram2021Genotypephenotype). The woozy mouse model, which carries a mutation in the Sil1 gene, is used to study the molecular mechanisms of impaired chaperone function and its effects on the nervous system and skeletal muscle (Buchkremer2016Sil1Mutant).

## Interactions
SIL1 is a nucleotide exchange factor that interacts primarily with the chaperone protein BiP, also known as GRP78. SIL1 facilitates the release of ADP from BiP, allowing ATP to bind, which is crucial for BiP's function in protein folding within the endoplasmic reticulum. The interaction between SIL1 and BiP involves the ARM domain of SIL1 wrapping around lobe IIb of BiP's nucleotide-binding domain, with additional contacts made with lobe Ib. This binding causes conformational changes that open the nucleotide-binding pocket, promoting ADP release (Ichhaporia2021Role; Yan2011Structural).

Mutations in SIL1 can disrupt its interaction with BiP, leading to diseases such as Marinesco-Sjögren syndrome. These mutations often result in a loss of SIL1's ability to bind BiP, affecting protein folding and leading to protein aggregation or degradation via ER-associated degradation (ERAD) (Inaguma2014; Ichhaporia2021Role).

SIL1 also interacts with other proteins, such as Mortalin and the small subunit of Calpain-1. Certain SIL1 variants, like the wildtype and p.R92W, can bind to POC1A, a protein linked to centrosome and Golgi function, while pathogenic mutants like p.G312R interact with ERj3, another BiP-binding protein (Gatz2019Identification).


## References


[1. (Bayram2021Genotypephenotype) Nurettin Bayram, Ayşe Kaçar Bayram, Hülya-Sevcan Daimagüler, Hormos Salimi Dafsari, Daniel Bamborschke, Gökhan Uyanik, Murat Erdogan, Cemal Özsaygılı, Emine Pangal, İsa Yuvaci, Selim Doğanay, Hakan Gümüş, Hüseyin Per, Heinz Jungbluth, and Sebahattin Çırak. Genotype-phenotype correlations in ocular manifestations of marinesco–sjögren syndrome: case report and literature review. European Journal of Ophthalmology, 32(3):NP92–NP97, June 2021. URL: http://dx.doi.org/10.1177/11206721211021291, doi:10.1177/11206721211021291. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/11206721211021291)

[2. (Gatz2019Identification) Christian Gatz, Denisa Hathazi, Ute Münchberg, Stephan Buchkremer, Thomas Labisch, Ben Munro, Rita Horvath, Ana Töpf, Joachim Weis, and Andreas Roos. Identification of cellular pathogenicity markers for sil1 mutations linked to marinesco-sjögren syndrome. Frontiers in Neurology, June 2019. URL: http://dx.doi.org/10.3389/fneur.2019.00562, doi:10.3389/fneur.2019.00562. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2019.00562)

[3. (Buchkremer2016Sil1Mutant) Stephan Buchkremer, José Andrés González Coraspe, Joachim Weis, and Andreas Roos. Sil1-mutant mice elucidate chaperone function in neurological disorders. Journal of Neuromuscular Diseases, 3(2):169–181, May 2016. URL: http://dx.doi.org/10.3233/JND-160152, doi:10.3233/jnd-160152. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3233/JND-160152)

[4. (Yan2011Structural) Ming Yan, Jingzhi Li, and Bingdong Sha. Structural analysis of the sil1–bip complex reveals the mechanism for sil1 to function as a nucleotide-exchange factor. Biochemical Journal, 438(3):447–455, August 2011. URL: http://dx.doi.org/10.1042/bj20110500, doi:10.1042/bj20110500. This article has 64 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20110500)

[5. (Anttonen2008Novel) Anna-Kaisa Anttonen, Eija Siintola, Lisbeth Tranebjaerg, Nobue K Iwata, Emilia K Bijlsma, Hiroyuki Meguro, Yaeko Ichikawa, Jun Goto, Outi Kopra, and Anna-Elina Lehesjoki. Novel sil1 mutations and exclusion of functional candidate genes in marinesco–sjögren syndrome. European Journal of Human Genetics, 16(8):961–969, February 2008. URL: http://dx.doi.org/10.1038/ejhg.2008.22, doi:10.1038/ejhg.2008.22. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2008.22)

[6. (Ruggieri2022Genotypephenotype) Anna Giulia Ruggieri and Michele Sallese. Genotype-phenotype correlation and adaptive proteome reorganization in marinesco-sjögren syndrome. Italian Journal of Anatomy and Embryology, 126(2):71–75, December 2022. URL: http://dx.doi.org/10.36253/ijae-13802, doi:10.36253/ijae-13802. This article has 0 citations.](https://doi.org/10.36253/ijae-13802)

[7. (Behnke2015BiP) Julia Behnke, Matthias J. Feige, and Linda M. Hendershot. Bip and its nucleotide exchange factors grp170 and sil1: mechanisms of action and biological functions. Journal of Molecular Biology, 427(7):1589–1608, April 2015. URL: http://dx.doi.org/10.1016/j.jmb.2015.02.011, doi:10.1016/j.jmb.2015.02.011. This article has 157 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2015.02.011)

[8. (Ichhaporia2021Role) Viraj P. Ichhaporia and Linda M. Hendershot. Role of the hsp70 co-chaperone sil1 in health and disease. International Journal of Molecular Sciences, 22(4):1564, February 2021. URL: http://dx.doi.org/10.3390/ijms22041564, doi:10.3390/ijms22041564. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22041564)

[9. (Inaguma2014) Yutaka Inaguma, Nanako Hamada, Hidenori Tabata, Ikuko Iwamoto, Makoto Mizuno, Yoshiaki V Nishimura, Hidenori Ito, Rika Morishita, Motomasa Suzuki, Kinji Ohno, Toshiyuki Kumagai, and Koh‐ichi Nagata. <scp> sil1 </scp> , a causative cochaperone gene of <scp>m</scp> arinesco‐ <scp>s</scp> jögren syndrome, plays an essential role in establishing the architecture of the developing cerebral cortex. EMBO Molecular Medicine, 6(3):414–429, January 2014. URL: http://dx.doi.org/10.1002/emmm.201303069, doi:10.1002/emmm.201303069. This article has 37 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/emmm.201303069)

[10. (Bracher2014GrpE) Andreas Bracher and Jacob Verghese. GrpE, Hsp110/Grp170, HspBP1/Sil1 and BAG Domain Proteins: Nucleotide Exchange Factors for Hsp70 Molecular Chaperones, pages 1–33. Springer International Publishing, December 2014. URL: http://dx.doi.org/10.1007/978-3-319-11731-7_1, doi:10.1007/978-3-319-11731-7_1. This article has 49 citations.](https://doi.org/10.1007/978-3-319-11731-7_1)